These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 9618305

  • 1. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
    Miyazaki M, Ohashi R, Tsuji T, Mihara K, Gohda E, Namba M.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):873-80. PubMed ID: 9618305
    [Abstract] [Full Text] [Related]

  • 2. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH.
    Cancer Res; 2004 Jun 15; 64(12):4155-61. PubMed ID: 15205326
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J, Ammanamanchi S, Ko TC, Brattain MG.
    Cancer Res; 2003 Jun 15; 63(12):3340-6. PubMed ID: 12810668
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV.
    Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653
    [Abstract] [Full Text] [Related]

  • 5. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
    Hu X, Zhang X, Zhong Q, Fisher AB, Bryington M, Zuckerman KS.
    Oncogene; 2001 Oct 18; 20(47):6840-50. PubMed ID: 11687963
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US, Park SK, Lee YI, Park JG, Lee YI.
    Oncogene; 2000 Jul 13; 19(30):3384-94. PubMed ID: 10918595
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ, Yan S, Herr KD, Wenner CE.
    Cancer Res; 1995 Apr 01; 55(7):1413-6. PubMed ID: 7882344
    [Abstract] [Full Text] [Related]

  • 9. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA, Zhang D, Choo CK, Eckert RL, Jacobberger JW.
    Exp Cell Res; 2000 Aug 25; 259(1):149-57. PubMed ID: 10942587
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC, Iglehart JD, Marks JR.
    Cell Growth Differ; 1994 Dec 25; 5(12):1301-7. PubMed ID: 7696178
    [Abstract] [Full Text] [Related]

  • 11. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA, Bhattacharya N, Bani MR, Ben-David Y, Kerbel RS, Slingerland JM.
    Oncogene; 1996 Dec 05; 13(11):2447-57. PubMed ID: 8957087
    [Abstract] [Full Text] [Related]

  • 12. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.
    Zhang F, Taipale M, Heiskanen A, Laiho M.
    Oncogene; 2001 Sep 13; 20(41):5888-96. PubMed ID: 11593394
    [Abstract] [Full Text] [Related]

  • 13. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

  • 14. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G, Habbersett RC, Jia Y, Peterson SR, Lehnert BE, Bradbury EM, D'Anna JA.
    Oncogene; 1998 Feb 12; 16(6):721-36. PubMed ID: 9488036
    [Abstract] [Full Text] [Related]

  • 15. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC, Chen YQ.
    Oncogene; 1998 Sep 24; 17(12):1549-56. PubMed ID: 9794232
    [Abstract] [Full Text] [Related]

  • 16. Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells.
    Kang SH, Bang YJ, Jong HS, Seo JY, Kim NK, Kim SJ.
    Br J Cancer; 1999 Jun 24; 80(8):1144-9. PubMed ID: 10376964
    [Abstract] [Full Text] [Related]

  • 17. Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor.
    Shima N, Stolz DB, Miyazaki M, Gohda E, Higashio K, Michalopoulos GK.
    J Cell Physiol; 1998 Oct 24; 177(1):130-6. PubMed ID: 9731753
    [Abstract] [Full Text] [Related]

  • 18. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R.
    Oncogene; 1998 Oct 08; 17(14):1827-36. PubMed ID: 9778049
    [Abstract] [Full Text] [Related]

  • 19. Differential regulation of p27 and cyclin D1 by TGF-beta and EGF in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ, Yan S, Dolce C, Kinniburgh AJ, Wenner CE.
    J Cell Physiol; 1996 Sep 08; 168(3):510-20. PubMed ID: 8816905
    [Abstract] [Full Text] [Related]

  • 20. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy.
    Ohmori T, Yang JL, Price JO, Arteaga CL.
    Exp Cell Res; 1998 Dec 15; 245(2):350-9. PubMed ID: 9851876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.